Drug-resistant Candida glabrata infection in cancer patients.
about
Emerging Threats in Antifungal-Resistant Fungal PathogensCoping with stress and the emergence of multidrug resistance in fungiClinical perspectives on echinocandin resistance among Candida speciesEmerging issues with diagnosis and management of fungal infections in solid organ transplant recipientsEpidemiology and Risk Factors for Echinocandin Nonsusceptible Candida glabrata Bloodstream Infections: Data From a Large Multisite Population-Based Candidemia Surveillance Program, 2008-2014Clinical and microbiological characteristics, and impact of therapeutic strategies on the outcomes of children with candidemia.In vitro activity of econazole in comparison with three common antifungal agents against clinical Candida strains isolated from superficial infectionsStudy on the comparative activity of echinocandins on murine gut colonization by Candida albicans.Posttreatment Antifungal Resistance among Colonizing Candida Isolates in Candidemia Patients: Results from a Systematic Multicenter Study.Epidemiology and reporting of candidaemia in Belgium: a multi-centre study.Acquired Multidrug Antifungal Resistance in Candida lusitaniae during Therapy.Rate of FKS Mutations among Consecutive Candida Isolates Causing Bloodstream InfectionDose escalation studies with caspofungin against Candida glabrata.Antifungal Action of Methylene Blue Involves Mitochondrial Dysfunction and Disruption of Redox and Membrane Homeostasis in C. albicans.Inhibiting fungal multidrug resistance by disrupting an activator-Mediator interaction.Upregulation of the Adhesin Gene EPA1 Mediated by PDR1 in Candida glabrata Leads to Enhanced Host Colonization.Utility of in-house fluconazole disk diffusion susceptibility testing in the treatment of candidemia.Fluconazole and Echinocandin Resistance of Candida glabrata Correlates Better with Antifungal Drug Exposure Rather than with MSH2 Mutator Genotype in a French Cohort of Patients Harboring Low Rates of Resistance.Safety and Pharmacokinetics of CD101 IV, a Novel Echinocandin, in Healthy Adults.Pharmacokinetics of the Novel Echinocandin CD101 in Multiple Animal Species.The ever-evolving landscape of candidaemia in patients with acute leukaemia: non-susceptibility to caspofungin and multidrug resistance are associated with increased mortality.Mechanisms of echinocandin antifungal drug resistance.Drug resistance mechanisms and their regulation in non-albicans Candida species.Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus.Phenotypic and Molecular Evaluation of Echinocandin Susceptibility of Candida glabrata, Candida bracarensis, and Candida nivariensis Strains Isolated during 30 Years in Argentina.Echinocandin resistance and population structure of invasive Candida glabrata isolates from two university hospitals in Germany and Austria.Antifungal stewardship considerations for adults and pediatrics.Azole Resistance in Candida glabrata.Genetic Drivers of Multidrug Resistance in Candida glabrata.Successful treatment of pulmonary candidiasis and aspergillosis in patient with refractory Hodgkin lymphoma using micafungin - case study and brief literature reviewAn Avid Imitator.Cross-resistance between voriconazole and fluconazole for non-albicans Candida infection: a case-case-control study.Initial Treatment of Cancer Patients with Fluconazole-Susceptible Dose-Dependent Candida glabrata Fungemia: Better Outcome with an Echinocandin or Polyene Compared to an Azole?Differential Activity of the Oral Glucan Synthase Inhibitor SCY-078 against Wild-Type and Echinocandin-Resistant Strains of Candida Species.Updated practice guidelines for the diagnosis and management of aspergillosis: challenges and opportunities.Pharmacological Blockade of the Chemokine Receptor CCR1 Protects Mice from Systemic Candidiasis of Hematogenous Origin.T2 Magnetic Resonance for Fungal Diagnosis.Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance.Candida spp. airway colonization: A potential risk factor for Acinetobacter baumannii ventilator-associated pneumonia.Uncommon Candida Species Fungemia among Cancer Patients, Houston, Texas, USA.
P2860
Q26750816-85B5EB3E-27DE-4EC3-B919-BD81A3E99B2DQ27025256-0B360608-EFDF-4E38-9537-CB20BA890220Q28082538-3F7216AD-7376-4F50-8948-0FD97CAC15C5Q28084643-9126683E-8406-486D-9D24-7F332B958C99Q31032549-9B5D2EFD-EB8C-40FA-9206-3570207B6C12Q33683476-252679C7-B0F3-4DD6-BAF6-782648B3D426Q33851255-3A6FA76C-53B6-418D-AB4C-4489007FB403Q35633233-EE3DDB53-92B2-4D6B-B83C-794361B0C3C4Q35880078-64048334-200B-41A8-8ADF-C3A24934EACFQ36196229-006376AF-F0EA-42DF-B65A-A91FD8736591Q36290663-B5B0A1C3-B993-4F85-B815-8410C6D53250Q36290758-26C7A686-A416-4ACB-A372-D3594CAE0C98Q36376559-A03334E3-B3BF-4626-BBD4-44F505E3E595Q36658607-53009D7A-D588-455F-9C75-3750E8434305Q36883131-B3F39831-11A4-4126-9925-F176605776CBQ36891186-986F96B7-CE0B-4A4A-9DA7-90E8CC63254FQ37029566-20C92F2D-94CA-47BB-8657-9E82341A835AQ37528498-069ADE08-5C5F-4CB9-A363-7828474ED3ACQ37612980-DA0661A9-6371-4F57-A0F2-051E83FDD1F7Q37720796-73827B43-CFDD-4121-91DD-A8DC3B198860Q38412398-6522DD8A-4B71-4EAF-8D3D-805ECD2E3C66Q38550402-8B1297FF-9770-4478-9208-A8BFCB664E73Q38708362-3914974B-BDCD-4B0A-8443-950FB1848515Q38711698-B12074A8-1FDF-4506-BA01-4685B64F3368Q38810300-710765C0-A7E8-4766-BC88-D5CC15D6F36BQ38916677-49759EE4-6433-487C-9486-BAAA9EA9879EQ38944746-CA006F4C-0C98-4DDE-87A9-600960231B84Q38985818-6D65A7D5-DE85-44BA-B214-010F16A87DECQ39065051-8C6D8FCF-779D-4A1B-BF29-57368804D892Q39416431-AAE94EE7-71D5-4F9C-A53D-2EFF0A27E14CQ40119053-3F6387DB-2116-4D9A-850D-0D014ED0F87CQ40169961-29D79C8E-D04D-4FC5-8AC6-35EECE667B37Q40184271-74083CFA-203D-42B1-86AC-757FE9AB5596Q40202924-9129C225-1C63-4354-8AB2-1917F4DE9B82Q40349447-D4BC4F9A-4681-4CFF-B570-0316545747EFQ40403802-01A01FE0-F364-4C75-BDA4-62987B3D1559Q40454814-BF510BAB-78E0-4E0C-8A36-2B8A5DE32893Q40738359-826CD78A-EAF6-426C-A0B6-6D6EADB25BC8Q40746229-755A1BCE-8B97-4295-9932-6DBB91FE0F62Q40942390-3616BC19-0F7D-4BAF-8463-FCF9002082EC
P2860
Drug-resistant Candida glabrata infection in cancer patients.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Drug-resistant Candida glabrata infection in cancer patients.
@ast
Drug-resistant Candida glabrata infection in cancer patients.
@en
Drug-resistant Candida glabrata infection in cancer patients.
@nl
type
label
Drug-resistant Candida glabrata infection in cancer patients.
@ast
Drug-resistant Candida glabrata infection in cancer patients.
@en
Drug-resistant Candida glabrata infection in cancer patients.
@nl
prefLabel
Drug-resistant Candida glabrata infection in cancer patients.
@ast
Drug-resistant Candida glabrata infection in cancer patients.
@en
Drug-resistant Candida glabrata infection in cancer patients.
@nl
P2093
P2860
P356
P1476
Drug-resistant Candida glabrata infection in cancer patients.
@en
P2093
Dimitrios Farmakiotis
Dimitrios P Kontoyiannis
Jeffrey J Tarrand
P2860
P304
P356
10.3201/EID2011.140685
P577
2014-11-01T00:00:00Z